Collegium Pharmaceutical, Inc. COLL Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s deferred tax assets?
- Collegium Pharmaceutical, Inc. (COLL) reported deferred tax assets of $113.57M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s deferred tax assets changed year-over-year?
- Collegium Pharmaceutical, Inc.'s deferred tax assets increased by 23.9% year-over-year, from $91.67M to $113.57M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s deferred tax assets?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s deferred tax assets has grown at a 9.6% compound annual growth rate (CAGR), from $78.04M to $112.54M.
- What does deferred tax assets mean?
- Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.